Feb 04, 2019
Viracor Eurofins Launches Baloxavir marboxil (XOFLUZA(TM)) Influenza A Antiviral Resistance PCR for 2019 Flu Season
Jan 17, 2019
BioIQ White Paper Provides Insights for Employers on Tackling High Cost of Flu
Jan 14, 2019
January Results From the Clover Health Flu Shot Monitor Reveal That Only 63% of U.S. Seniors Have Been Immunized This Season
Dec 03, 2018
CVS Health Observes National Influenza Vaccination Week by Encouraging Families to Get Their Flu Shot
Nov 30, 2018
Clover Health Flu Shot Monitor Finds Only 60% of U.S. Seniors Have Been Immunized This Season
Nov 26, 2018
Outcome Health Announces Partnership with the Infectious Diseases Society of America Foundation
Nov 16, 2018
Seqirus Announces U.S. $140 Million Manufacturing Expansion to Meet Growing Demand for Innovative Cell-Based Influenza Vaccines
Nov 16, 2018
Seqirus Releases Real-World Data Indicating Significantly Greater Effectiveness of Cell-Based Seasonal Influenza Vaccines Compared to Standard Influenza Vaccine Options
Nov 08, 2018
New Poll Sheds Light On Flu Shot Disparity: 85 Percent Of Americans Know That Healthy Children Can Die From The Flu, Yet Half Of Parents Polled Still Haven't Gotten Their Children Vaccinated
Oct 31, 2018
Nasal Spray Vaccines Back in Play for 2018-2019 Flu Season
Oct 29, 2018
Clover Health Flu Shot Monitor Finds Only 41% of U.S. Seniors Have Gotten Immunized This Season
Oct 24, 2018
BiondVax's Universal Flu Vaccine Phase 3 Clinical Trial Completes First Season's Enrollment of 4,098 Participants
Oct 24, 2018
FDA approves new drug to treat influenza
Oct 23, 2018
Seqirus Receives FDA Approval of AFLURIA® QUADRIVALENT (Influenza Vaccine) for People Six Months of Age and Older in the U.S.
Oct 09, 2018
Mucinex Survey Reveals Millions Of Americans Hide Being Sick
Oct 03, 2018
Seqirus Presents Data at IDWeek Demonstrating Cell-Derived Viruses Have a Closer Match to Circulating Influenza Viruses Compared to Egg-derived Viruses Used in the Production of Influenza Vaccines
Oct 03, 2018
Seqirus Presents Favorable Outcomes Data for Adjuvanted Trivalent Influenza Vaccine (FLUAD®) at 6th Annual IDWeek
Oct 01, 2018
GC Pharma Receives Korea's MFDS Approval of GCFLU Quadrivalent (Influenza Vaccine) for persons 6 months and older
Oct 01, 2018
After Severe Flu 2017 Season, More Americans Planning to Get Their Flu Shots
Oct 01, 2018
DispatchHealth Launches Traveling Flu Crew to Deliver Affordable On-demand Urgent Care This Flu Season